Cronos Group Inc. (NASDAQ:CRON – Get Free Report) crossed below its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $3.32 and traded as low as $3.25. Cronos Group shares last traded at $3.27, with a volume of 911,176 shares trading hands.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on CRON shares. Weiss Ratings raised shares of Cronos Group from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. Wall Street Zen upgraded Cronos Group from a “hold” rating to a “buy” rating in a research report on Saturday, November 7th. Zacks Research raised Cronos Group from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 22nd. Finally, TD Securities reaffirmed a “buy” rating on shares of Cronos Group in a research report on Monday, September 28th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $2.30.
Get Our Latest Stock Report on Cronos Group
Cronos Group Stock Down 0.6%
The business has a fifty day simple moving average of $3.32 and a two-hundred day simple moving average of $2.90. The company has a market cap of $1.16 billion, a P/E ratio of 39.88 and a beta of 0.96.
Cronos Group (NASDAQ:CRON – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $0.04 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.01. Cronos Group had a net margin of 28.04% and a return on equity of 2.56%. The business had revenue of $63.45 million for the quarter, compared to the consensus estimate of $51.15 million. On average, equities analysts predict that Cronos Group Inc. will post 0.16 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in CRON. Goldman Sachs Group Inc. lifted its stake in shares of Cronos Group by 23.5% during the 3rd quarter. Goldman Sachs Group Inc. now owns 671,031 shares of the company’s stock valued at $2,214,000 after buying an additional 127,795 shares in the last quarter. Jump Financial LLC bought a new position in shares of Cronos Group in the third quarter worth about $234,000. State Street Corp purchased a new stake in shares of Cronos Group during the third quarter worth about $404,000. Private Advisor Group LLC grew its position in shares of Cronos Group by 10.0% during the third quarter. Private Advisor Group LLC now owns 32,681 shares of the company’s stock worth $108,000 after purchasing an additional 2,984 shares in the last quarter. Finally, HighTower Advisors LLC bought a new stake in Cronos Group during the 3rd quarter valued at approximately $1,198,000. 8.71% of the stock is owned by hedge funds and other institutional investors.
Cronos Group Company Profile
Cronos Group is a cannabinoid company that develops, produces, and markets cannabis and cannabis-derived products. Its business includes cultivation, processing, product development, and distribution. The company sells products in categories such as dried cannabis flower, pre-rolls, vaporizers, edibles, and extracts. Its brand portfolio includes Spinach and PEACE NATURALS. Founded in 2012 and headquartered in Toronto, Cronos serves consumers in Canada and select international markets, including Israel.
Featured Articles
- Five stocks we like better than Cronos Group
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.
